SNGX net incomeQ3 2026-$1.12M
SNGX net income was -$1.12M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$2.53M a year earlier. For the full fiscal 2025 it was -$11.08M, compared with -$8.27M in fiscal 2024.
Soligenix Inc. (SNGX) financials
For the twelve months ended Sep 30, 2026, Soligenix Inc. reported -$8.83M of net income.
- Net income, TTM
- -$8.83M
- Cash
- $9.02M
- Market cap
- $7.5M
FY2016FY2024
FY2016FY2025
SNGX revenue and earnings growth
SNGX EPSQ3 2026-$0.05
SNGX diluted EPS was -$0.05 in fiscal Q3 2026 (ended Sep 30, 2026). For the full fiscal 2025 it was -$2.14.
SNGX free cash flowQ4 2025-$2.75M
SNGX free cash flow was -$2.75M in fiscal Q4 2025 (ended Dec 31, 2025). For the full fiscal 2025 it was -$10.27M.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $119.4K | $839.4K | $948.9K | $824.3K | $2.36M | $4.63M | $5.24M | $5.43M | $10.45M |
| Cost of revenue | - | $119.4K | $742.0K | $550.8K | $728.6K | $1.82M | $3.57M | $4.60M | $4.31M | $8.43M |
| Gross profit | - | $0 | $97.3K | $398.1K | $95.6K | $538.5K | $1.06M | $643.7K | $1.12M | $2.02M |
| Research and development | $7.49M | $5.22M | $3.31M | $7.94M | $8.19M | $9.80M | $8.12M | $6.75M | $5.51M | $4.30M |
| Selling, general and admin | $4.36M | $4.22M | $4.48M | $6.69M | $5.01M | $4.33M | $3.48M | $2.95M | $3.21M | $3.43M |
| Operating income | -$11.85M | -$9.44M | -$7.70M | -$14.24M | -$13.10M | -$18.59M | -$10.54M | -$9.06M | -$7.59M | -$5.71M |
| Pre-tax income | -$11.59M | -$8.68M | -$7.91M | -$14.95M | -$13.42M | -$18.53M | -$9.97M | -$8.90M | -$7.56M | -$3.78M |
| Income tax | -$506.6K | -$409.1K | -$1.77M | -$1.15M | -$864.7K | -$836.9K | -$610.7K | - | -$416.8K | -$530.1K |
| Net income | -$11.08M | -$8.27M | -$6.14M | -$13.80M | -$12.55M | -$17.69M | -$9.36M | -$8.90M | -$7.15M | -$3.25M |
| EPS, basic | -$2.14 | -$4.98 | -$12.66 | -$4.81 | -$4.69 | -$9.60 | -$7.20 | -$10.20 | -$17.40 | -$13.95 |
| EPS, diluted | -$2.14 | -$4.98 | -$12.66 | -$4.81 | -$4.69 | -$9.60 | -$7.20 | -$10.20 | -$17.40 | -$20.10 |
| Diluted shares | 5.2M | 1.7M | 484,995 | 2.9M | 2.7M | 1.8M | 1.3M | 878,543.6 | 409,615.8 | 238,905.8 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $7.94M | $7.82M | $8.45M | $13.36M | $26.04M | $18.68M | $5.42M | $8.98M | $7.81M | $8.77M |
| Current assets | $8.85M | $8.83M | $9.51M | $13.85M | $26.57M | $19.47M | $7.49M | $10.34M | $9.42M | $10.11M |
| Total assets | $9.24M | $8.97M | $9.80M | $14.28M | $26.87M | $19.89M | $7.78M | $10.49M | $9.55M | $10.27M |
| Current liabilities | $3.70M | $4.85M | $6.15M | $16.52M | $6.29M | $6.08M | $6.31M | $4.21M | $3.23M | $2.87M |
| Total debt | - | $0 | $1.01M | $0 | - | - | - | - | - | - |
| Total liabilities | $3.94M | $4.85M | $7.27M | $16.75M | $16.15M | $16.15M | $6.32M | $4.21M | - | - |
| Shareholders' equity | $5.29M | $4.12M | $2.52M | -$2.47M | $10.72M | $3.74M | $1.46M | $6.28M | $6.32M | $7.40M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.27M | -$8.40M | -$8.60M | -$12.65M | -$11.74M | -$11.45M | -$7.51M | -$7.24M | -$6.51M | -$4.98M |
| Capital expenditures | $5.9K | - | - | - | - | - | - | - | - | - |
| Free cash flow | -$10.27M | - | - | - | - | - | - | - | - | - |
| Investing cash flow | -$5.9K | - | - | -$13.1K | -$11.8K | -$7.1K | -$24.7K | -$925 | -$26.3K | -$7.2K |
| Financing cash flow | $10.39M | $7.76M | $3.66M | $76.8K | $19.06M | $24.68M | $4.01M | $8.42M | $5.57M | $8.84M |
| Stock-based compensation | $587.6K | $329.8K | $370.2K | $333.4K | $361.6K | $409.9K | $376.3K | $380.9K | $489.8K | $575.0K |
| Depreciation and amortization | - | - | - | - | $34.2K | $62.4K | $54.5K | $44.1K | $68.6K | $89.9K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | -85.8% | -11.5% | 15.1% | -65.1% | -49.0% | -11.7% | -3.5% | -48.0% | 19.2% |
| Gross margin | - | 0.0% | 11.6% | 42.0% | 11.6% | 22.8% | 22.9% | 12.3% | 20.7% | 19.3% |
| Operating margin | - | -7907.7% | -917.1% | -1500.6% | -1589.2% | -787.7% | -227.7% | -172.8% | -139.8% | -54.6% |
| Net margin | - | -6925.1% | -731.6% | -1454.1% | -1522.7% | -749.7% | -202.1% | -169.8% | -131.6% | -31.1% |
| Return on equity | -209.4% | -200.7% | -243.4% | - | -117.1% | -472.7% | -642.1% | -141.7% | -113.1% | -43.9% |
| Return on assets | -120.0% | -92.2% | -62.7% | -96.6% | -46.7% | -88.9% | -120.3% | -84.8% | -74.8% | -31.6% |
| Current ratio | 2.39 | 1.82 | 1.55 | 0.84 | 4.22 | 3.20 | 1.19 | 2.46 | 2.92 | 3.52 |
| Debt to equity | - | 0.00 | 0.40 | - | - | - | - | - | - | - |
Income statement
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $0 | $0 | $2.3K | $117.0K | $244.8K |
| Cost of revenue | - | - | - | - | - | - | - | $0 | $0 | $2.3K | $117.0K | $221.5K |
| Gross profit | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $23.3K |
| Research and development | $357.0K | $974.1K | $1.78M | $2.28M | $1.58M | $1.68M | $1.94M | $2.66M | $968.7K | $501.2K | $1.10M | $777.5K |
| Selling, general and admin | $1.02M | $1.13M | $1.10M | $1.19M | $996.6K | $1.09M | $1.08M | $1.05M | $896.5K | $1.24M | $1.02M | $1.38M |
| Operating income | -$1.38M | -$2.10M | -$2.88M | -$3.47M | -$2.58M | -$2.76M | -$3.03M | -$3.71M | -$1.87M | -$1.74M | -$2.12M | -$2.14M |
| Pre-tax income | -$1.12M | -$1.99M | -$2.82M | -$3.40M | -$2.53M | -$2.70M | -$2.95M | -$3.40M | -$1.72M | -$1.64M | -$1.92M | -$2.43M |
| Income tax | - | - | - | - | - | - | - | - | - | - | - | -$606.6K |
| Net income | -$1.12M | -$1.99M | -$2.82M | -$2.90M | -$2.53M | -$2.70M | -$2.95M | -$2.99M | -$1.72M | -$1.64M | -$1.92M | -$1.82M |
| EPS, basic | -$0.05 | -$0.12 | -$0.28 | - | -$0.58 | -$0.82 | -$0.97 | - | -$0.78 | -$1.31 | -$2.91 | - |
| EPS, diluted | -$0.05 | -$0.12 | -$0.28 | - | -$0.58 | -$0.82 | -$0.97 | - | -$0.78 | -$1.31 | -$2.91 | - |
| Diluted shares | 22.1M | 16.0M | 10.2M | - | 4.3M | 3.3M | 3.0M | - | 2.2M | 1.3M | 657,698 | - |
Balance sheet
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $9.02M | $9.81M | $6.03M | $7.94M | $10.53M | $5.10M | $7.30M | $7.82M | $9.84M | $9.41M | $7.09M | $8.45M |
| Current assets | $9.17M | $10.17M | $6.57M | $8.85M | $10.88M | $5.32M | $7.64M | $8.83M | $10.31M | $9.66M | $7.82M | $9.51M |
| Total assets | $9.46M | $10.50M | $6.92M | $9.24M | $9.24M | $5.76M | $7.75M | $8.97M | $10.48M | $9.87M | $8.06M | $9.80M |
| Current liabilities | $3.06M | $3.67M | $3.62M | $3.70M | $3.42M | $3.63M | - | $4.85M | $4.53M | $6.35M | $7.21M | $6.15M |
| Total debt | - | - | - | - | - | - | - | $0 | - | - | - | $1.01M |
| Total liabilities | $3.21M | $3.85M | $3.83M | $3.94M | $3.70M | $3.93M | $3.85M | $4.85M | $4.54M | $6.40M | $7.29M | $7.27M |
| Shareholders' equity | $6.26M | $6.65M | $3.09M | $5.29M | $7.60M | $1.83M | $3.90M | $4.12M | $5.94M | $3.46M | $768.4K | $2.52M |
Cash flow
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.42M | -$1.71M | -$2.36M | -$2.75M | -$2.93M | -$2.74M | -$1.85M | -$2.23M | -$2.91M | -$1.92M | -$1.34M | -$1.83M |
| Capital expenditures | - | - | - | $2.0K | $608 | - | - | - | - | - | - | - |
| Free cash flow | - | - | - | -$2.75M | -$2.93M | - | - | - | - | - | - | - |
| Investing cash flow | - | - | - | -$2.0K | -$608 | - | - | - | - | - | - | - |
| Financing cash flow | $636.4K | $5.49M | $451.0K | $157.9K | $8.36M | $545.6K | $1.32M | $242.9K | $3.29M | $4.23M | -$9.0K | -$46.2K |
| Stock-based compensation | $86.6K | $116.0K | $121.2K | $320.1K | $104.3K | $99.5K | $63.6K | $155.5K | $56.6K | $57.7K | $60.0K | $141.1K |
Key ratios
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | - | - | - | - | - | - | -100.0% | -100.0% | -98.9% | -54.5% | -33.1% |
| Gross margin | - | - | - | - | - | - | - | - | - | 0.0% | 0.0% | 9.5% |
| Operating margin | - | - | - | - | - | - | - | - | - | -74495.1% | -1809.0% | -873.3% |
| Net margin | - | - | - | - | - | - | - | - | - | -70217.8% | -1636.6% | -743.4% |
| Current ratio | 3.00 | 2.77 | 1.81 | 2.39 | 3.18 | 1.47 | - | 1.82 | 2.28 | 1.52 | 1.08 | 1.55 |
| Debt to equity | - | - | - | - | - | - | - | 0.00 | - | - | - | 0.40 |
Source: XBRL data Soligenix Inc. files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-10, first reported Nov 10, 2016; 1-for-15, first reported Mar 31, 2023.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
SNGX peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| SNGX | - | - | -$8.83M | - | $7.5M |
| CTXR | - | - | -$54.33M | - | $13.4M |
| PCSA | - | - | -$13.44M | - | $5.2M |
SNGX FAQ
4 questionsIs SNGX profitable?
No. Soligenix Inc. reported a net loss of $8.83M for the twelve months ended Sep 30, 2026.How much cash and debt does SNGX have?
Soligenix Inc. reported $9.02M in cash and cash equivalents on its most recent balance sheet in SEC filings.When did SNGX last report financial results?
The latest statements here come from Soligenix Inc.'s 10-Q filed on Nov 6, 2026, covering the period ended Sep 30, 2026.Where does this SNGX financial data come from?
Quantisnow builds these statements from the structured XBRL data Soligenix Inc. files with the SEC. It is provided for information only and is not investment advice.